Literature DB >> 17573352

Structural basis of sterol binding by NPC2, a lysosomal protein deficient in Niemann-Pick type C2 disease.

Sujuan Xu1, Brian Benoff, Heng-Ling Liou, Peter Lobel, Ann M Stock.   

Abstract

NPC2 is a small lysosomal glycoprotein that binds cholesterol with submicromolar affinity. Deficiency in NPC2 is the cause of Niemann-Pick type C2 disease, a fatal neurovisceral disorder characterized by accumulation of cholesterol in lysosomes. Here we report the crystal structure of bovine NPC2 bound to cholesterol-3-O-sulfate, an analog that binds with greater apparent affinity than cholesterol. Structures of both apo-bound and sterol-bound NPC2 were observed within the same crystal lattice, with an asymmetric unit containing one molecule of apoNPC2 and two molecules of sterol-bound NPC2. As predicted from a previously determined structure of apoNPC2, the sterol binds in a deep hydrophobic pocket sandwiched between the two beta-sheets of NPC2, with only the sulfate substituent of the ligand exposed to solvent. In the two available structures of apoNPC2, the incipient ligand-binding pocket, which ranges from a loosely packed hydrophobic core to a small tunnel, is too small to accommodate cholesterol. In the presence of sterol, the pocket expands, facilitated by a slight separation of the beta-strands and substantial reorientation of some side chains, resulting in a perfect molding of the pocket around the hydrocarbon portion of cholesterol. A notable feature is the repositioning of two aromatic residues at the tunnel entrance that are essential for NPC2 function. The NPC2 structures provide evidence of a malleable binding site, consistent with the previously documented broad range of sterol ligand specificity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17573352      PMCID: PMC3645284          DOI: 10.1074/jbc.M703848200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  Crystal structure of human GM2-activator protein with a novel beta-cup topology.

Authors:  C S Wright; S C Li; F Rastinejad
Journal:  J Mol Biol       Date:  2000-12-01       Impact factor: 5.469

2.  The crystal structure of a major dust mite allergen Der p 2, and its biological implications.

Authors:  U Derewenda; J Li; Z Derewenda; Z Dauter; G A Mueller; G S Rule; D C Benjamin
Journal:  J Mol Biol       Date:  2002-04-19       Impact factor: 5.469

3.  Deletion of the helical motif in the intestinal fatty acid-binding protein reduces its interactions with membrane monolayers: Brewster angle microscopy, IR reflection-absorption spectroscopy, and surface pressure studies.

Authors:  F Wu; B Corsico; C R Flach; D P Cistola; J Storch; R Mendelsohn
Journal:  Biochemistry       Date:  2001-02-20       Impact factor: 3.162

4.  Structure of sterol carrier protein 2 at 1.8 A resolution reveals a hydrophobic tunnel suitable for lipid binding.

Authors:  T Choinowski; H Hauser; K Piontek
Journal:  Biochemistry       Date:  2000-02-29       Impact factor: 3.162

5.  Structure and lipid transport mechanism of a StAR-related domain.

Authors:  Y Tsujishita; J H Hurley
Journal:  Nat Struct Biol       Date:  2000-05

6.  A porcine homolog of the major secretory protein of human epididymis, HE1, specifically binds cholesterol.

Authors:  N Okamura; S Kiuchi; M Tamba; T Kashima; S Hiramoto; T Baba; F Dacheux; J L Dacheux; Y Sugita; Y Z Jin
Journal:  Biochim Biophys Acta       Date:  1999-06-10

7.  Identification of HE1 as the second gene of Niemann-Pick C disease.

Authors:  S Naureckiene; D E Sleat; H Lackland; A Fensom; M T Vanier; R Wattiaux; M Jadot; P Lobel
Journal:  Science       Date:  2000-12-22       Impact factor: 47.728

8.  Frontal lobe atrophy due to a mutation in the cholesterol binding protein HE1/NPC2.

Authors:  Hans H Klünemann; Milan Elleder; Wolfgang E Kaminski; Karen Snow; Janis M Peyser; John F O'Brien; David Munoz; Gerd Schmitz; Helmfried E Klein; William W Pendlebury
Journal:  Ann Neurol       Date:  2002-12       Impact factor: 10.422

Review 9.  ML -- a conserved domain involved in innate immunity and lipid metabolism.

Authors:  Naohiro Inohara; Gabriel Nuñez
Journal:  Trends Biochem Sci       Date:  2002-05       Impact factor: 13.807

10.  Biophysical studies and intracellular destabilization of pH-sensitive liposomes.

Authors:  F Van Bambeke; A Kerkhofs; A Schanck; C Remacle; E Sonveaux; P M Tulkens; M P Mingeot-Leclercq
Journal:  Lipids       Date:  2000-02       Impact factor: 1.646

View more
  84 in total

1.  Characterization of a spontaneous novel mutation in the NPC2 gene in a cat affected by Niemann Pick type C disease.

Authors:  Stefania Zampieri; Ezio Bianchi; Carlo Cantile; Roberta Saleri; Bruno Bembi; Andrea Dardis
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

2.  Crystal structure of soluble MD-1 and its interaction with lipid IVa.

Authors:  Sung-il Yoon; Minsun Hong; Gye Won Han; Ian A Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

3.  Characterization of the Niemann-Pick C pathway in alveolar type II cells and lamellar bodies of the lung.

Authors:  Blair R Roszell; Jian-Qin Tao; Kevin J Yu; Shaohui Huang; Sandra R Bates
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-02-24       Impact factor: 5.464

Review 4.  The potential of histone deacetylase inhibitors in Niemann - Pick type C disease.

Authors:  Michael Maceyka; Sheldon Milstien; Sarah Spiegel
Journal:  FEBS J       Date:  2013-09-23       Impact factor: 5.542

5.  Niemann-Pick type C 1 function requires lumenal domain residues that mediate cholesterol-dependent NPC2 binding.

Authors:  Maika S Deffieu; Suzanne R Pfeffer
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

6.  Therapeutic potential of cyclodextrins in the treatment of Niemann-Pick type C disease.

Authors:  Benny Liu
Journal:  Clin Lipidol       Date:  2012-06

Review 7.  Niemann-Pick C2 (NPC2) and intracellular cholesterol trafficking.

Authors:  Judith Storch; Zhi Xu
Journal:  Biochim Biophys Acta       Date:  2009-02-13

Review 8.  Treatment of Niemann--pick type C disease by histone deacetylase inhibitors.

Authors:  Paul Helquist; Frederick R Maxfield; Norbert L Wiech; Olaf Wiest
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

Review 9.  The LDL receptor.

Authors:  Joseph L Goldstein; Michael S Brown
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-04       Impact factor: 8.311

10.  Investigation of N-aryl-3-alkylidenepyrrolinones as potential Niemann-Pick type C disease therapeutics.

Authors:  Casey C Cosner; John T Markiewicz; Pauline Bourbon; Christopher J Mariani; Olaf Wiest; Madalina Rujoi; Anton I Rosenbaum; Amy Y Huang; Frederick R Maxfield; Paul Helquist
Journal:  J Med Chem       Date:  2009-10-22       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.